Literature DB >> 15357847

The opioid system in the gastrointestinal tract.

C Sternini1, S Patierno, I-S Selmer, A Kirchgessner.   

Abstract

Mu-, delta- and kappa-opioid receptors (ORs) mediate the effects of endogenous opioids and opiate drugs. Here we report (1) the distribution of muOR in the guinea-pig and human gastrointestinal tract in relation to endogenous ligands, to functionally distinct structures in the gut and to deltaOR and kappaOR; and (2) the ligand-induced muOR endocytosis in enteric neurones using in vitro and in vivo models. In the guinea pig, muOR immunoreactivity is confined mainly to the myenteric plexus. MuOR myenteric neurones are most numerous in the small intestine, followed by the stomach and the proximal colon. MuOR immunoreactive fibres are dense in the muscle layer and the deep muscular plexus, where they are in close association with interstitial cells of Cajal. This distribution closely matches the pattern of enkephalin. MuOR enteric neurones comprise functionally distinct populations of neurones of the ascending and descending pathways of the peristaltic reflex. In human gut, muOR immunoreactivity is localized to myenteric and submucosal neurones and to immune cells of the lamina propria. DeltaOR immunoreactivity is located in both plexuses where it is predominantly in varicose fibres in the plexuses, muscle and mucosa, whereas kappaOR immunoreactivity appears to be confined to the myenteric plexus and to bundles of fibres in the muscle. MuOR undergoes endocytosis in a concentration-dependent manner, in vitro and in vivo. Pronounced muOR endocytosis is observed in neurones from animals that underwent abdominal surgery that has been shown to induce delay in gastrointestinal transit. We can conclude that all three ORs are localized to the enteric nervous system with differences among species, and that muOR endocytosis can be utilized as a means to visualize enteric neurones activated by opioids and sites of opioid release.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15357847     DOI: 10.1111/j.1743-3150.2004.00553.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  69 in total

1.  Morphine induces μ opioid receptor endocytosis in guinea pig enteric neurons following prolonged receptor activation.

Authors:  Simona Patierno; Laura Anselmi; Ingrid Jaramillo; David Scott; Rachel Garcia; Catia Sternini
Journal:  Gastroenterology       Date:  2010-11-09       Impact factor: 22.682

Review 2.  Evolving paradigms in the treatment of opioid-induced bowel dysfunction.

Authors:  Jakob Lykke Poulsen; Christina Brock; Anne Estrup Olesen; Matias Nilsson; Asbjørn Mohr Drewes
Journal:  Therap Adv Gastroenterol       Date:  2015-11       Impact factor: 4.409

3.  Lubiprostone reverses the inhibitory action of morphine on mucosal secretion in human small intestine.

Authors:  Xiaohong Sun; Xiyu Wang; Guo-Du Wang; Yun Xia; Sumei Liu; Meihua Qu; Bradley J Needleman; Dean J Mikami; W Scott Melvin; Laura M Bohn; Ryuji Ueno; Jackie D Wood
Journal:  Dig Dis Sci       Date:  2010-12-23       Impact factor: 3.199

Review 4.  Intestinal motility disturbances in intensive care patients pathogenesis and clinical impact.

Authors:  Sonja Fruhwald; Peter Holzer; Helfried Metzler
Journal:  Intensive Care Med       Date:  2006-11-18       Impact factor: 17.440

5.  The effect of opioids on the development of postoperative intra-abdominal adhesions.

Authors:  Amir Khorram-Manesh; Jalal Vahedian Ardakani; Hamid Reza Behjati; Gunnar Nylund; Dick Delbro
Journal:  Dig Dis Sci       Date:  2006-03       Impact factor: 3.199

6.  The putative role of endogenous and exogenous opiates in inflammatory bowel disease.

Authors:  S Collins; M Verma-Gandhu
Journal:  Gut       Date:  2006-06       Impact factor: 23.059

Review 7.  The opioid component of delayed gastrointestinal recovery after bowel resection.

Authors:  Timothy L Beard; John B Leslie; Jeffrey Nemeth
Journal:  J Gastrointest Surg       Date:  2011-04-15       Impact factor: 3.452

8.  Opiate-induced oesophageal dysmotility.

Authors:  R E Kraichely; A S Arora; J A Murray
Journal:  Aliment Pharmacol Ther       Date:  2009-12-08       Impact factor: 8.171

9.  The vagus regulates histamine mobilization from rat stomach ECL cells by controlling their sensitivity to gastrin.

Authors:  P Norlén; P Ericsson; M Kitano; M Ekelund; R Håkanson
Journal:  J Physiol       Date:  2005-03-03       Impact factor: 5.182

Review 10.  Intensive Care Unit-acquired infection as a side effect of sedation.

Authors:  Saad Nseir; Demosthenes Makris; Daniel Mathieu; Alain Durocher; Charles-Hugo Marquette
Journal:  Crit Care       Date:  2010-03-15       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.